Effects of risperidone on the acquisition and reinstatement of the conditioned place preference induced by MDMA

Brain Research Bulletin

Volumn 98, Issue , 2013, Pages 36-43

  Roger Sanchez C ^a   Rodriguez Arias M ^a   Minarro J ^a   Aguilar, M A ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Adolescence; Conditioned place preference; MDMA; Mice; Risperidone

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; DOPAMINE; DOPAMINE TRANSPORTER; RISPERIDONE; SEROTONIN;

ADOLESCENT BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVERSION; CONDITIONING; CONTROLLED STUDY; CORPUS STRIATUM; DRUG ABUSE; MALE; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; WESTERN BLOTTING;

ADOLESCENCE; CONDITIONED PLACE PREFERENCE; MDMA; MICE; RISPERIDONE;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; ANTIPSYCHOTIC AGENTS; CONDITIONING (PSYCHOLOGY); CORPUS STRIATUM; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HALLUCINOGENS; MALE; MICE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; REWARD; RISPERIDONE; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 84881529476     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2013.07.009     Document Type: Article

References (48)

1. Aguilar M.A., Rodríguez-Arias M., Miñarro J. Neurobiological mechanisms of the reinstatement of drug-conditioned place preference. Brain Research Reviews 2009, 59:253-277.
2. Amato L., Minozzi S., Pani P.P., Davoli M. Antipsychotic medications for cocaine dependence. Cochrane Database of Systematic Review 2007, D006306.
3. Beninger R.J. Dissociating the effects of altered dopaminergic function on performance and learning. Brain Research Bulletin 1989, 23:365-371.
4. Bilsky E.J., Montegut M.J., Nichols M.L., Reid L.D. CGS 10746B, a novel dopamine release inhibitor, blocks the establishment of cocaine and MDMA conditioned place preferences. Pharmacology Biochemistry and Behavior 1998, 59:215-220.
5. Bilsky E.J., Reid L.D. MDL72222, a serotonin 5-HT3 receptor antagonist, blocks MDMA's ability to establish a conditioned place preference. Pharmacology Biochemistry and Behavior 1991, 39:509-512.
6. Brackins T., Brahm N.C., Kissack J.C. Treatments for methamphetamine abuse: a literature review for the clinician. Journal of Pharmacy Practice 2011, 24:541-550.
7. Braida D., Iosuè S., Pegorini S., Sala M. 3,4-Methylenedioxymethamphetamine-induced conditioned place preference (CPP) is mediated by endocannabinoid system. Pharmacological Research 2005, 51:177-182.
8. Brennan K.A., Carati C., Lea R.A., Fitzmaurice P.S., Schenk S. Effect of D1-like and D2-like receptor antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine self-administration in rats. Behavioural Pharmacology 2009, 20:688-694.
9. Brière F.N., Fallu J.S., Janosz M., Pagani L.S. Prospective associations between meth/amphetamine (speed) and MDMA (ecstasy) use and depressive symptoms in secondary school students. Journal of Epidemiology & Community Health 2012, 66:990-994.
10. Cadoni C., Solinas M., Pisanu A., Zernig G., Acquas E., Di Chiara G. Effect of 3,4-methylendioxymethamphetamine (MDMA, ecstasy) on dopamine transmission in the nucleus accumbens shell and core. Brain Research 2005, 1055:143-148.
11. Colussi-Mas J., Wise R.J., Howard A., Schenk S. Drug seeking in response to a priming injection of MDMA in rats: relationship to initial sensitivity to self-administered MDMA and dorsal striatal dopamine. International Journal of Neuropsychopharmacology 2010, 13:1315-1327.
12. Cottler L.B., Womack S.B., Compton W.M., Ben Abdallah A. Ecstasy abuse and dependence among adolescents and young adults: applicability and reliability of DSM-IV criteria. Human Psychopharmacology 2001, 16:599-606.
13. Daniela E., Brennan K., Gittings D., Hely L., Schenk S. Effect of SCH 23390 on (+/-)-3,4-methylenedioxymethamphetamine hyperactivity and self-administration in rats. Pharmacology Biochemistry and Behavior 2004, 77:745-750.
14. Daza-Losada M., Rodríguez-Arias M., Aguilar M.A., Miñarro J. Acquisition and reinstatement of MDMA-induced conditioned place preference in mice pre-treated with MDMA or cocaine during adolescence. Addiction Biology 2009, 14:447-456.
15. Daza-Losada M., Ribeiro Do Couto B., Manzanedo C., Aguilar M.A., Rodríguez-Arias M., Miñarro J. Rewarding effects and reinstatement of MDMA-induced CPP in adolescent mice. Neuropsychopharmacology 2007, 32:1750-1759.
16. Degenhardt L., Bruno R., Topp L. Is ecstasy a drug of dependence?. Drug and Alcohol Dependence 2010, 107:1-10.
17. Doly S., Bertran-Gonzalez J., Callebert J., Bruneau A., Banas S.M., Belmer A., Boutourlinsky K., Hervé D., Launay J., Maroteaux L. Role of serotonin via 5-HT2B receptors in the reinforcing effects of MDMA in mice. PLoS ONE 2009, 4:e7952.
18. EMCDDA Annual report on the state of the drugs problem in Europe 2012, (accessed 09.02.13). http://www.emcdda.europa.eu/publications/annual-report/2012.
19. Fantegrossi W.E., Ullrich T., Rice K.C., Woods J.H., Winger G. 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement. Psychopharmacology 2002, 161:356-364.
20. Forget B., Wertheim C., Mascia P., Pushparaj A., Goldberg S.R., Le Foll B. Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction. Neuropsychopharmacology 2010, 35:1751-1760.
21. Gudelsky G.A., Yamamoto B.K., Nash J.F. Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists. European Journal of Pharmacology 1994, 264:325-330.
22. Gudelsky G.A., Yamamoto B.K. Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons. Pharmacology Biochemistry and Behavior 2008, 90:198-207.
23. Hagino Y., Takamatsu Y., Yamamoto H., Iwamura T., Murphy D.L., Uhl G.R., Sora I., Ikeda K. Effects of MDMA on extracellular dopamine and serotonin levels in mice lacking dopamine and/or serotonin transporters. Current Neuropharmacology 2011, 9:91-95.
24. Heffner T.G., Hartman J.A., Seiden L.S. A rapid method for the regional dissection of the rat brain. Pharmacology Biochemistry and Behavior 1980, 13:453-456.
25. Kalivas P.W., O'Brien C. Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology 2008, 33:166-180.
26. Kelly T.M., Daley D.C., Douaihy A.B. Treatment of substance abusing patients with comorbid psychiatric disorders. Addictive Behaviors 2012, 37:11-24.
27. Koch S., Galloway M.P. MDMA induced dopamine release in vivo: role of endogenous serotonin. Journal of Neural Transmission 1997, 104:135-146.
28. Leung K.S., Ben Abdallah A., Copeland J., Cottler L.B. Modifiable risk factors of ecstasy use: risk perception, current dependence, perceived control, and depression. Addictive Behaviors 2010, 35:201-208.
29. Leysen J.E., Gommeren W., Eens A., de Chaffoy de Courcelles D., Stoof J.C., Janssen P.A. Biochemical profile of risperidone, a new antipsychotic. Journal of Pharmacology and Experimental Therapeutics 1988, 247:661-670.
30. Manzanedo C., Rodríguez-Arias M., Daza-Losada M., Maldonado C., Aguilar M.A., Miñarro J. Effect of the CB1 cannabinoid agonist WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference in mice. Behavioral and Brain Functions 2010, 6:19.
31. 2A receptors in MDMA reinforcement and cue-induced reinstatement of MDMA-seeking behaviour. International Journal of Neuropsychopharmacology 2011, 14:927-940.
32. Ravindran A.V., Bradbury C., McKay M., da Silva T.L. Novel uses for risperidone: focus on depressive, anxiety and behavioral disorders. Expert Opinion on Pharmacotherapy 2007, 8:1693-1710.
33. Ribeiro Do Couto B., Aguilar M.A., Manzanedo C., Rodríguez-Arias M., Miñarro J. NMDA glutamate but not dopamine antagonists blocks drug-induced reinstatement of morphine place preference. Brain Research Bulletin 2005, 64:493-503.
34. Ribeiro Do Couto B., Rodríguez-Arias M., Fuentes S., Gagliano H., Armario A., Miñarro J., Aguilar M.A. Adolescent pre-exposure to ethanol or MDMA prolongs the conditioned rewarding effects of MDMA. Physiology & Behavior 2011, 103:585-593.
35. Ribeiro Do Couto B., Daza-Losada M., Rodríguez-Arias M., Nadal R., Guerri C., Summavielle T., Miñarro J., Aguilar M.A. Adolescent pre-exposure to ethanol and 3,4-methylenedioxymethylamphetamine (MDMA) increases conditioned rewarding effects of MDMA and drug-induced reinstatement. Addiction Biology 2012, 17:588-600.
36. Rodríguez-Arias M., Manzanedo C., Roger-Sánchez C., Ribeiro Do Couto B., Aguilar M.A., Miñarro J. Effect of adolescent exposure to WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference. rogress in Neuro-Psychopharmacology & Biological Psychiatry 2010, 34:166-171.
37. Rudnick G., Wall S.C. The molecular mechanism of ecstasy [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:1817-1821.
38. Salwan J., Woldu H., Rosen A., Katz C.L. Application for Inclusion to the 19th Expert Committee on the Selection and Use of Essential Medicines: RISPERIDONE 2013, http://www.who.int/selection_medicines/committees/expert/19/applications/Risperidone_24_A_Ad_Final.pdf.
39. Sanchez C.J., Bailie T.M., Wu W.R., Li N., Sorg B.A. Manipulation of dopamine d1-like receptor activation in the rat medial prefrontal cortex alters stress- and cocaine-induced reinstatement of conditioned place preference behavior. Neuroscience 2003, 119:497-505.
40. Schenk S., Gittings D., Colussi-Mas J. Dopaminergic mechanisms of reinstatement of MDMA-seeking behaviour in rats. British Journal of Pharmacology 2011, 162:1770-1780.
41. Schenk S. MDMA self-administration in laboratory animals: a summary of the literature and proposal for future research. Neuropsychobiology 2009, 60:130-136.
42. Schmidt C.J., Levin J.A., Lovenberg W. In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain. Biochemical Pharmacology 1987, 36:747-755.
43. Shioda K., Nisijima K., Yoshino T., Kuboshima K., Iwamura T., Yui K., Kato S. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats. Neurotoxicology 2008, 29:1030-1036.
44. Smith R.J., Aston-Jones G. α(2) Adrenergic and imidazoline receptor agonists prevent cue-induced cocaine seeking. Biological Psychiatry 2011, 70:712-719.
45. Stahl S.M. The Prescriber's Guide (Stahl's Essential Psychopharmacology) 2011, Cambridge University Press, Cambridge, UK, ISBN-13: 978-0521173643. 4th ed.
46. Tzschentke T.M. Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addiction Biology 2007, 12:227-462.
47. Vidal-Infer A., Roger-Sánchez C., Daza-Losada M., Aguilar M.A., Miñarro J., Rodríguez-Arias M. Role of the dopaminergic system in the acquisition, expression and reinstatement of MDMA-induced conditioned place preference in adolescent mice. PLoS ONE 2012, 7:e43107.
48. Zhang X.Y., Kosten T.A. Prazosin, an alpha-1 adrenergic antagonist, reduces cocaine-induced reinstatement of drug-seeking. Biological Psychiatry 2005, 57:1202-1204.